Cardiology Associates Research, LLC
Welcome,         Profile    Billing    Logout  
 12 Trials 
21 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Calhoun, William
WARRIOR, NCT03417388: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Active, not recruiting
4
2476
US
High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL
University of Florida, United States Department of Defense
Coronary Artery Disease
09/24
12/24
VMR, NCT05331170: Viral Mucosal Reprogramming

Recruiting
2
75
US
Research Grade RG-RV
The University of Texas Medical Branch, Galveston, Mohammad Zaidan, MD
Asthma, Allergic Rhinitis, Cat Allergy, Healthy
05/27
05/27
Stone, James
NCT04680026: A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)

Active, not recruiting
2
150
Canada, US, RoW
HBI-3000, sulcardine sulfate, Placebo
HUYABIO International, LLC.
Atrial Fibrillation
12/24
12/24
C-TRACT, NCT03250247: Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The Trial)

Recruiting
N/A
250
US
Stents
Washington University School of Medicine, Ontario Clinical Oncology Group (OCOG), Massachusetts General Hospital, Saint Luke's Mid America Heart Institute
Deep Vein Thrombosis, Venous Stasis, Venous Insufficiency, Venous Leg Ulcer, Venous Reflux, Post Thrombotic Syndrome
01/26
04/26
NCT04190186: Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

Completed
N/A
55
US
Insertable Cardiac Monitor, BioMonitor3® or future generation of Biotronik ICM
University of Rochester, Biotronik, Inc.
Persistent Atrial Fibrillation
02/24
02/24
NCT03643224: DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

Completed
N/A
376
Europe, Canada, US, RoW
Radiofrequency Ablation
Medtronic Cardiac Rhythm and Heart Failure
Persistent Atrial Fibrillation, Atrial Fibrillation
10/24
10/24
Bertolet, Barry
VICTORION-2P, NCT05030428: Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Active, not recruiting
3
17004
Europe, Canada, Japan, US, RoW
Inclisiran sodium 300 mg, Placebo
Novartis Pharmaceuticals
Atherosclerotic Cardiovascular Disease
10/27
10/27
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Recruiting
3
14000
Europe, Canada, US, RoW
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml
Novartis Pharmaceuticals
Primary Prevention of Atherosclerotic Cardiovascular Disease
03/29
03/29
NCT05562934: An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

Completed
2
194
Europe, Japan, US, RoW
Experimental drug, Placebo
Novartis Pharmaceuticals
Resistant Hypertension
07/24
08/24
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29
FORWARD PAD, NCT05858905: IDE Study With the Shockwave Mini S IVL Catheter

Active, not recruiting
N/A
75
US
Intravascular Lithotripsy
Shockwave Medical, Inc.
Peripheral Arterial Disease
04/24
04/25
ALLEVIATE-HF, NCT04452149: Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

Active, not recruiting
N/A
826
US
Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download, Medication intervention
Medtronic Cardiac Rhythm and Heart Failure
Heart Failure NYHA Class II, Heart Failure NYHA Class III
05/25
05/25
MAGICAL ISR, NCT05908331: MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Recruiting
N/A
492
US
Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA)
Concept Medical Inc., Cardiovascular Research Foundation, New York
In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
09/25
02/28
LUX-Dx TRENDS, NCT04790344: Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

Active, not recruiting
N/A
525
US
Investigational LUX-Dx ICM Implant
Boston Scientific Corporation
Heart Failure
05/26
06/26
ELEGANCE, NCT04674969: Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Recruiting
N/A
5000
Europe, Canada, US, RoW
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Boston Scientific Corporation
Peripheral Vascular Diseases
01/28
01/28
Stein, Bernardo
MAGICAL ISR, NCT05908331: MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Recruiting
N/A
492
US
Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA)
Concept Medical Inc., Cardiovascular Research Foundation, New York
In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
09/25
02/28
Ray, Yvonne
NCT04680026: A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)

Active, not recruiting
2
150
Canada, US, RoW
HBI-3000, sulcardine sulfate, Placebo
HUYABIO International, LLC.
Atrial Fibrillation
12/24
12/24
COSIRA-II, NCT05102019: Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Recruiting
N/A
380
Canada, US
Arm 1: treatment with Neovasc Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry
Neovasc Inc., Shockwave Medical, Inc.
Refractory Angina
06/25
12/28
NCT04190186: Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

Completed
N/A
55
US
Insertable Cardiac Monitor, BioMonitor3® or future generation of Biotronik ICM
University of Rochester, Biotronik, Inc.
Persistent Atrial Fibrillation
02/24
02/24
AIM HIGHer, NCT05064709: Assessment of CCM in HF With Higher Ejection Fraction

Recruiting
N/A
1500
US
Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System, CCM Group (CCM ON), OPTIMIZER™ Smart Mini System, Sham Group (CCM OFF)
Impulse Dynamics
Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Heart Failure With Moderately Reduced Ejection Fraction, Diastolic Heart Failure
02/25
02/26
Watts, Tina
WARRIOR, NCT03417388: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Active, not recruiting
4
2476
US
High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL
University of Florida, United States Department of Defense
Coronary Artery Disease
09/24
12/24

Download Options